OVEREXPRESSION OF P53 PROTEIN IN BARRETTS SYNDROME WITH MALIGNANT TRANSFORMATION

被引:72
|
作者
FLEJOU, JF
POTET, F
MUZEAU, F
LEPELLETIER, F
FEKETE, F
HENIN, D
机构
[1] HOP BEAUJON, DEPT PATHOL, F-92118 CLICHY, FRANCE
[2] HOP BEAUJON, DEPT DIGEST SURG, F-92118 CLICHY, FRANCE
[3] UNIV PARIS 07, INSERM, U239, PARIS, FRANCE
关键词
D O I
10.1136/jcp.46.4.330
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To study the overexpression of p53 protein in Barrett's oesophagus with adenocarcinoma, and to correlate this expression with the pathological features of Barrett's syndrome. Methods-Immunohistochemical staining was performed on frozen sections with a monoclonal antibody directed against wild type and mutated p53 protein (Pab 1801). Eleven cases of Barrett's adenocarcinoma were studied, seven of which had extensive sampling of benign Barrett's mucosa. Results-Eight of 11 adenocarcinomas overexpressed the p53 protein. Both early and advanced tumours were positive. In Barrett's mucosa around the p53 positive tumours, high grade dysplasia was positive; low grade dysplasia and non-dysplastic mucosa were negative. Conclusions-P53 gene mutation with ensuing p53 protein overexpression is a common feature of Barrett's adenocarcinoma, both at early and advanced stages. This mutation appears as a relatively late event during the neoplastic transformation of Barrett's oesophagus.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 50 条
  • [41] p53 gene mutation, tumor p53 protein overexpression, and serum p53 autoantibody generation in patients with breast cancer
    Angelopoulou, K
    Yu, H
    Bharaj, B
    Giai, M
    Diamandis, EP
    CLINICAL BIOCHEMISTRY, 2000, 33 (01) : 53 - 62
  • [42] Comparison of P53 protein overexpression with P53 mutation in bladder cancer: Clinical and biologic aspects
    Vet, JAM
    Bringuier, PP
    Schaafsma, HE
    Witjes, JA
    Debruyne, FMJ
    Schalken, JA
    LABORATORY INVESTIGATION, 1995, 73 (06) : 837 - 843
  • [43] OVEREXPRESSION OF P53 IS A LATE EVENT IN THE DEVELOPMENT OF MALIGNANT-MELANOMA
    LASSAM, NJ
    FROM, L
    KAHN, HJ
    CANCER RESEARCH, 1993, 53 (10) : 2235 - 2238
  • [44] P53 GENE-MUTATIONS IN BARRETTS METAPLASIA
    FRONZA, G
    CAMPOMENOSI, P
    CONIO, M
    BOGLIOLO, M
    URBINI, S
    PICASSO, M
    ASTE, H
    INGA, A
    IANNONE, R
    MENICHINI, P
    CAMORIANO, A
    LAPERTOSA, G
    BARACCHINI, P
    ABBONDANDOLO, A
    GASTROENTEROLOGY, 1995, 108 (04) : A471 - A471
  • [45] P53 IMMUNOREACTIVITY IN BARRETTS METAPLASIA, DYSPLASIA, AND CARCINOMA
    RICE, TW
    GOLDBLUM, JR
    FALK, GW
    TUBBS, RR
    KIRBY, TJ
    CASEY, G
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 108 (06): : 1132 - 1137
  • [47] PROGNOSTIC VALUE OF P53 IN BARRETTS-ESOPHAGUS
    KRISHNADATH, KK
    VANBLANKENSTEIN, M
    TILANUS, HW
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1995, 7 (01) : 81 - 84
  • [48] IMMUNOHISTOCHEMICAL ANALYSIS OF P53 PROTEIN OVEREXPRESSION IN NORMAL, PREMALIGNANT, AND MALIGNANT-TISSUES OF THE CERVIX UTERI
    HOLM, R
    SKOMEDAL, H
    HELLAND, A
    KRISTENSEN, G
    BORRESEN, AL
    NESLAND, JM
    JOURNAL OF PATHOLOGY, 1993, 169 (01): : 21 - 26
  • [49] Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma
    Chang, SC
    Lin, JK
    Lin, TC
    Liang, WY
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (01) : 65 - 75
  • [50] p53 protein overexpression in laryngeal squamous cell papillomas
    Poljak, M
    Gale, N
    Kambic, V
    Luzar, B
    ANTICANCER RESEARCH, 1997, 17 (3C) : 2201 - 2205